Skip to content

Zoetis ZTS Net Income

Net Income at other companies

Merck & Co. logo
Merck & Co.MRK
-$4.24B-183%
Neogen logo
NeogenNEOG
-$17M-56.0%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$278.45M+14.7%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$24.02M+15.1%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$57M-14.9%
Tractor Supply Company logo
Tractor Supply CompanyTSCO
$164.52M-8.3%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's net income?
Zoetis (ZTS) reported net income of $601M in Q1 2026.
How has Zoetis's net income changed year-over-year?
Zoetis's net income decreased by 0.2% year-over-year, from $602M to $601M.
What is the long-term trend for Zoetis's net income?
Over 4 years (2021 to 2025), Zoetis's net income has grown at a 6.7% compound annual growth rate (CAGR), from $2.04B to $2.64B.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.